Начало › Ендометриален рак › Калифорния › Los Angeles
Клинични проучвания за Ендометриален рак в Los Angeles, CA
34 проучвания за Ендометриален рак търсят участници в обекти в и около Los Angeles (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Набиране на участнициФаза 3
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
A Study of PHST001 in Advanced Solid Tumors
Набиране на участнициФаза 1
- USC Norris Comprehensive Cancer Center, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- University of California - Los Angeles, Los Angeles
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Research Site, Los Angeles
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Набиране на участнициФаза 2
- Cedars-Sinai Medical Center, Los Angeles
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Набиране на участнициФаза 2
- Research Site, Los Angeles
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Набиране на участнициФаза 1/2
- California Research Institute (CRI), Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Набиране на участнициФаза 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- University of Southern California, Los Angeles
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- START Los Angeles, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Набиране на участнициФаза 1/2
- Children's Hospital Los Angeles, Los Angeles
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Набиране на участнициФаза 2
- Cedars Sinai Medical Center, Los Angeles
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Набиране на участнициФаза 1
- Valkyrie Clinical Trials, Los Angeles
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
Набиране на участници
- University of California at Los Angeles, Los Angeles
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Набиране на участнициФаза 1
- START - Los Angeles, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- University of California, Los Angeles (UCLA), Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Набиране на участнициФаза 1/2
- Los Angeles Cancer Network, Los Angeles
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- UCLA - Hematology/Oncology Clinical Research Unit, Los Angeles
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Набиране на участнициФаза 1/2
- University of California Los Angeles Medical Center, Los Angeles
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Набиране на участнициФаза 1
- START Los Angeles, Los Angeles
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Набиране на участнициФаза 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Ellison Clinic at Saint John's, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Набиране на участнициФаза 1
- Cedars-Sinai Medical Center, Los Angeles
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Набиране на участнициФаза 2
- UCLA, Los Angeles
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Набиране на участнициФаза 1
- UCLA - JCCC Clinical Research Unit, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Набиране на участнициФаза 1/2
- University of Southern California, Los Angeles
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Набиране на участнициФаза 1/2
- University of Southern California, Los Angeles
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Набиране на участнициФаза 2
- University of Southern California, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Cedars Sinai Medical Center, Los Angeles
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Набиране на участнициФаза 1/2
- The Angeles Clinic and Research Institute, Los Angeles
Проучвания за Ендометриален рак в други градове
- Houston, TX68 проучвания
- New York City, NY52 проучвания
- Boston, MA50 проучвания
- Arlington, VA39 проучвания
- Nashville, TN38 проучвания
- St. Louis, MO29 проучвания
- Philadelphia, PA28 проучвания
- San Antonio, TX27 проучвания
- Columbus, OH25 проучвания
- Oklahoma City, OK25 проучвания
- Chicago, IL25 проучвания
- Queens, NY25 проучвания
Други проучвания в Los Angeles
- Рак на белия дроб с недребноклетъчен тип87 проучвания
- Рак (всички видове)74 проучвания
- Рак на гърдата73 проучвания
- Рак на простатата61 проучвания
- Колоректален рак59 проучвания
- Метастатичен рак57 проучвания
- Рак на яйчниците50 проучвания
- Рак на белия дроб45 проучвания
- Плоскоклетъчен карцином на главата и шията42 проучвания
- Рак на панкреаса35 проучвания
- Меланом34 проучвания
- Тройно негативен рак на гърдата27 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.